Valeant Board Tells CEO To Cooperate With Senators

Valeant Pharmaceuticals International Inc.'s board on April 11 took an unusual move in declaring it had asked the company's soon-to-be-exiting CEO Michael Pearson to cooperate with the US Senate Committee on Aging's subpoena for a deposition.